Abstract:Objective:To explore the thyroid hormone levels of perimenopausal depressed patients with anxious characteristics before and after treatment, and further analyze the relationship of anxious symptoms with thyroid hormone levels.Methods:Perimenopausal depressed patients with Hamilton Depression Scale-24 (HAMD-24) score≥20were recruited, HAMA-14was used to assess anxiety level, and patients with anxious characteristics was defined as HAMA-14score＞7.Health subjects with age and education matched were also recruited.Patients were treated with oral escitalopram for 8weeks and clinical symptoms were assessed at the baseline, 4th and 8th week of treatment.Results:A total of 113patients enrolled finally in the study were divided into anxiety group (81patients, 19cases lost) and without anxiety group (52patients, 15cases lost) , and 40health subjects were recruited.There were significant differences on the serum levels of FT4within the group (F=5.668, P＜0.01) , among three groups (F=4.917, P＜0.01) and group×time interaction effect (F=3.685, P＜0.01) .The serum level of FT4of depressed patients with anxiety symptoms at baseline was significantly higher than those without anxious symptoms (t=3.004, P＜0.01) .The serum level of FT4decreased gradually among depressed patients both with and without anxiety symptoms after the treatment, and there were significant differences on serum level of FT4at each time point in anxiety group (F=14.736, P＜0.001) .There were significant differences on serum level of TSH at baseline among three groups (P=0.003) , and the serum level of TSH was significantly lower in the anxiety group than that in the health group (t=-2.600, P＜0.05) .There was no statistical significance on within-subjects effects and the group×time interaction effect (P＞0.05) .Serum levels of FT4and body mass factor scores were all negatively correlated at baseline, 4th and 8th week of treatment (P＜0.05) .In the anxiety group, there were negative correlation between the serum level of FT4and weight factor of HAMD-14at baseline, 4th and 8th week of treatment (P＜0.05) ;there were positive correlations between the serum level of FT4and total score of HAMA-14, somatic anxiety, mental anxiety at baseline, 4th and 8th week respectively (P＜0.05) .Conclusion:There are significant correlations between anxiety symptoms of perimenopausal depressed patients and the serum level of FT4.It may be a potential way for improving anxiety symptoms to regulate thyroid hormone levels.

Serum Thyroid Hormone Levels Before and after Treatment in Patients with Treatment-Resistant Depression

Thyroid hormone levels before and after treatment of perimenopausal depressed patients

The Relevant Research of Thyroid Hormones and Clinical Features in Treatment-Resistant Depression

The thyroid hormone level of perimenopausal depressed patients with anxious characteristics

The Impact of Quetiapine Monotherapy or in Combination with Lithium on the Thyroid Function in Patients with Bipolar Depression: A Retrospective Study

Study on the changes of thyroid hormone levels in patients with perimenopausal depressive episode

Thyroid hormones abnormalities in patients with depression

Comparison of Hair Thyroid Hormones Between First‐episode and Recurrent Patients with Depression in Female Chinese

Study on the level of free thyroxin in first-episode depressions with varied severity

Hypothalamic-pituitary-thyroid-axis function in treatment resistant depression.

Association between thyroid function and major depression

Changes of Related Serum Hormone Levels after Operation or Withdrawal of Drug Substitution Treatment in Patients with Differentiated Thyroid Carcinoma

Relationships between depression level and serum inflammatory factors and thyroxine levels in patients with malignant bone tumors associated with depression

Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: A machine learning analysis of the real-world based study.

Comparison of the level of thyroid hormones between patients with major depressive disorder and dysthymic disorder

The research about changes of thyroid function in patients with depression

Correlation of thyroid hormones, antibodies and depression

The clinical effects of Selenious yeast tablets combined with Levothyroxine sodium in patients with hypothyroidism

Hair thyroid hormones concentration in patients with depression changes with disease episodes in female Chinese

Association of Anxiety and Depressive Symptoms with Thyroid Hormone Concentrations in Patients with Primary Bone Tumors

Clinical Evaluation of Various Thyroid Hormones on Thyroid Function